COVID-19 vaccine design: the Janus face of immune enhancement.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

103 citing papers in PubMed, 3 syntheses or guidelines pooled it.

1. Coronavirus (SARS-CoV-2): a systematic review for potential vaccines.Human vaccines & immunotherapeutics · 2022
   Pooled it
2. Public mental health problems during COVID-19 pandemic: a large-scale meta-analysis of the evidence.Translational psychiatry · 2021
   Pooled it
3. A systematic review and meta-analysis on correlation of weather with COVID-19.Scientific reports · 2021
   Pooled it
4. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial.The Lancet. Infectious diseases · 2021
   Trial
5. Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials.JAMA · 2020
   Trial
6. Antibody-dependent enhancement of coronaviruses.International journal of biological sciences · 2025
   Review
7. Preclinical assessment of a recombinant RBD-Fc fusion protein as SARS-CoV-2 candidate vaccine.European journal of microbiology & immunology · 2024
   Article
8. Immune responses in COVID-19 patients: Insights into cytokine storms and adaptive immunity kinetics.Heliyon · 2024
   Review
9. Research progress on emulsion vaccine adjuvants.Heliyon · 2024
   Review
10. Strategies and Trends in COVID-19 Vaccination Delivery: What We Learn and What We May Use for the Future.Vaccines · 2023
    Article
11. An overview of the vaccine platforms to combat COVID-19 with a focus on the subunit vaccines.Progress in biophysics and molecular biology · 2023
    Review
12. State of the art in epitope mapping and opportunities in COVID-19.Future science OA · 2023
    Review
13. Review on Approved and Inprogress COVID-19 Vaccines.Iranian journal of pharmaceutical research : IJPR · 2022
    Review
14. SARS-CoV-2 vaccines: A double-edged sword throughout rapid evolution of COVID-19.Cell biology international · 2022
    Review
15. The resurgence risk of COVID-19 in China in the presence of immunity waning and ADE: A mathematical modelling study.Vaccine · 2022
    Article
16. A potent, broadly protective vaccine against SARS-CoV-2 variants of concern.NPJ vaccines · 2022
    Article
17. A Single-Administration Microneedle Skin Patch for Multi-Burst Release of Vaccine against SARS-CoV-2.Advanced materials technologies · 2022
    Article
18. COVID-19 and plasma cells: Is there long-lived protection?Immunological reviews · 2022
    Review
19. High viral loads: what drives fatal cases of COVID-19 in vaccinees? - an autopsy study.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2022
    Article
20. COVID-19 vaccine development: milestones, lessons and prospects.Signal transduction and targeted therapy · 2022
    Review

43 more citing papers are in PubMed but not listed here.

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as